Research Grants show all

NIH26NSF20

Patents show all

75Issued22Applications

SEC Filings show all

D16

SEC Form D Funding Events

DateOfferedSoldType
2014-05-30$7,117,068$4,960,867Equity
2013-04-18$7,305,429$5,071,495Equity, Option to Acquire
2013-03-15Indefinite$0Option to Acquire
2012-08-03$2,000,000$2,000,000Equity
2012-01-06$350,000$350,000Equity
2011-07-22$3,950,000$3,950,000Equity
2011-07-22$50,000$50,000Equity
2011-03-14Indefinite$0Option to Acquire
2011-03-11$5,756,343$5,555,274Equity, Option to Acquire
2010-06-23$275,382$275,382Equity
2010-06-23$116,500$116,500Equity
2010-06-23$167,068$167,068Equity
2010-06-23$131,722$131,722Equity
2010-05-06$41,923,908$37,163,577Equity, Option to Acquire
2010-03-22Indefinite$3,328,147Debt
2005-02-24UnknownUnknownOther (Paper Filing)

Key Executives

  • Christopher R McCleary
    Executive Officer
  • Randy Eccker
    Executive Officer, Director
  • Dan Aton
    Executive Officer, Director
  • Gregg G. Brandon
    Executive Officer
  • John H Wyant
    Director
  • Mark K Wright
    Director
  • George M Weiss
    Director
  • John Oppenheimer
    Director
  • Brian Fitzgerald
    Executive Officer
  • Robert Simmons
    Executive Officer
  • Christopher R. McCleary
    Executive Officer, Director
  • John H. Wyant
    Director
  • Christopher Noe
    Director
  • George Weiss
    Director
  • Glenn T. Reiger
    Director
  • Brian H. Fitzgerald
    Executive Officer
  • Gregg G Brandon
    Executive Officer
  • Jeff Dilley
    Executive Officer
  • Glenn T Reiger
    Director
  • Glenn T. Rieger
    Director
  • John Wyant
    Director
  • Mark Hudgins
    Executive Officer
  • Tim Hedke
    Executive Officer
  • Archit Shah
    Executive Officer
  • Tom Lynch
    Director
  • Matthew Bairos
    Executive Officer
  • Jennifer Dunham
    Director
  • George M. Weiss
    Director
  • John Krasznekewicz
    Director
  • Thomas Lynch
    Director
  • Shah Archit
    Executive Officer
  • Stephen B. Kaplan
    Executive Officer